Donor lymphocyte infusion
Donor lymphocyte infusion What every physician needs to know: Donor leukocyte infusion (DLI) has several indications after both myeloablative and non-myeloablative allogeneic stem cell transplantation (SCT). It is predominately used to treat and prevent relapse after SCT by exploiting the graft-versus-tumor effect (GVT) of donor derived T cells. It is also used to maximize donor…
